Hypertensive patients who have already had cardiovascular complications (such as a heart attack or stroke), who are diabetic, or suffering from kidney failure, who have several risk factors or have been exposed to a single extreme factor (e.g. heavy smokers, massive hypercholesterolemia) are classified as those being at a high cardiovascular risk already, and must be treated to the utmost without any necessity to stratify their risks further.

Less severely hypertensive patients (who fortunately, are the majority) can assess their risk of experiencing a lethal cardiovascular event by entering some baseline data into the coloured table derived from the SCORE study

http://www.escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf

p. 1775-76 - to differentiate high and low risk according to country

It is, in fact, sufficient to identify themselves on the basis of gender, smoking or non-smoking status, age category, maximum arterial pressure (systolic) and total cholesterolemia. If you are taking medication to lower blood cholesterol, you should use the values that you had before the treatment.

Risk is assessed as very high if it is greater than or equal to 10, as high if it is between 5 and 9, and moderate if between 1 and 4.

The risk estimate is raised by on average one category if there are parallel conditions, like a sedentary lifestyle, obesity, low "good" cholesterol (HDL), high triglycerides, a family history of dyslipidaemia, a family history of premature cardiovascular disease, renal failure, an age above those included on the sheets, the presence of asymptomatic lesions on ultrasound examination of the carotid arteries.

Deep Dive for registered Doctors

This article has additional & reserved content for registered doctors. Please log in or create a new profile to access this insights.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

Healthcare professionals and consumers are asked to report any suspected adverse reactions via the national reporting system.

All information on this site does not in any way replace the judgment of a specialist physician, the only one authorized to make advice and to express a medical opinion.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of this site have already been set. To find out more about the cookies we use and how to delete them, see our privacy policy.